Hygena Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 25.50 Cr
- Paid Up Capital ₹ 25.50 Cr
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 220.10 Cr
- Revenue Growth %
- Profit Growth -362.62%
- Ebitda -238.85%
- Net Worth 1083.99%
- Total Assets 2160.19%
About Hygena Life Sciences
Hygena Life Sciences Private Limited (HLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 August 2020 (Four years and five months 26 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.50 Cr and a paid-up capital of Rs 25.50 Cr.
The company currently has active open charges totaling ₹220.10 Cr.
Harpreet Singh and Baldev Kaur serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233DL2020PTC367705
-
Company No.
367705
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Aug 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Hygena Life Sciences?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harpreet Singh | Director | 08-Aug-2020 | Current |
Baldev Kaur | Director | 19-Sep-2023 | Current |
Financial Performance of Hygena Life Sciences.
Hygena Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 362.62% decrease in profit. The company's net worth Soared by an impressive increase of 1083.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hygena Life Sciences?
Unlock access to Hygena Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹220.10 Cr
₹0
Charges Breakdown by Lending Institutions
- Sbicap Trustee Company Limited : 220.00 Cr
- Hdfc Bank Limited : 0.10 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
11 Oct 2024 | Sbicap Trustee Company Limited | ₹45.00 Cr | Open |
19 Jul 2023 | Sbicap Trustee Company Limited | ₹175.00 Cr | Open |
07 Mar 2023 | Hdfc Bank Limited | ₹0.95 M | Open |
How Many Employees Work at Hygena Life Sciences?
Hygena Life Sciences has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hygena Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hygena Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.